PLK1
Showing 1 - 25 of 37
Recurrent Chronic Myelomonocytic Leukemia, Refractory Chronic Myelomonocytic Leukemia Trial in Rochester (Biospecimen
Recruiting
- Recurrent Chronic Myelomonocytic Leukemia
- Refractory Chronic Myelomonocytic Leukemia
- Biospecimen Collection
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)
Recruiting
- Small-cell Lung Cancer
- Small Cell Lung Carcinoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 29, 2022
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal
Recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- +11 more
- Cobimetinib
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 22, 2022
Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Onvansertib
- +3 more
-
Phoenix, Arizona
- +5 more
Dec 15, 2022
Metastatic Colorectal Cancer, KRAS Gene Mutation Trial in United States (Onvansertib, Bevacizumab, FOLFIRI)
Active, not recruiting
- Metastatic Colorectal Cancer
- KRAS Gene Mutation
- Onvansertib
- +2 more
-
Phoenix, Arizona
- +6 more
Nov 10, 2022
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +5 more
- CFI-400945
- +2 more
-
Duarte, California
- +7 more
Jul 20, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Adenocarcinoma Trial in
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- +5 more
- Questionnaire Administration
- Tin Sn 117m Pentetate
-
Lexington, KentuckyUniversity of Kentucky/Markey Cancer Center
Nov 26, 2022
Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)
Recruiting
- Melanoma Stage III
- +2 more
- Interleukin-2
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Dec 6, 2022
Recessive Dystrophic Epidermolysis Bullosa Trial in Philadelphia (Rigosertib Sodium, Quality-of-Life Assessment)
Recruiting
- Recessive Dystrophic Epidermolysis Bullosa
- Rigosertib Sodium
- Quality-of-Life Assessment
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 31, 2021
Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung
Unknown status
- Non-Small Cell Lung Cancer
- Tissue Collection
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Jan 28, 2021
Depression, Anxiety, Mental Health Issue Trial in Hong Kong (Improving Access to Community Therapies (iACT))
Recruiting
- Depression
- +4 more
- Improving Access to Community Therapies (iACT)
-
Hong Kong, China
- +20 more
Oct 26, 2023
Metastatic Melanoma Trial in United States (High Dose Interleukin-2, Ipilimumab)
Terminated
- Metastatic Melanoma
- High Dose Interleukin-2
- Ipilimumab
-
Tucson, Arizona
- +11 more
Dec 1, 2020
Colorectal Cancer With Hepatic Metastases, Pancreas Cancer With Hepatic Metastase, Gastric Cancer With Hepatic Metastase Trial
Completed
- Colorectal Cancer With Hepatic Metastases
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 2, 2018
Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)
Recruiting
- Sarcoma,Soft Tissue
- Selinexor 20 MG
- Gemcitabine
-
Tenerife, Canarias, Spain
- +10 more
Oct 27, 2023
Patients of Sepsis Complicated With Gastrointestinal Dysfunction
Not yet recruiting
- Sepsis
- Gastrointestinal Dysfunction
-
Tianjin, ChinaTianjin Nankai Hospital
Nov 22, 2020
Sepsis, Intestinal Dysfunction Trial in Tianjin (electroacupuncture treatment, sham electroacupuncture treatment)
Not yet recruiting
- Sepsis
- Intestinal Dysfunction
- electroacupuncture treatment
- sham electroacupuncture treatment
-
Tianjin, ChinaElectroacupuncture Apparatus
Nov 25, 2020
Metastatic Melanoma Trial in United States (vemurafenib + HD IL-2)
Terminated
- Metastatic Melanoma
- vemurafenib + HD IL-2
-
Tucson, Arizona
- +20 more
Jan 28, 2021
Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)
Active, not recruiting
- Kidney Cancer
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jun 21, 2022
Frailty, Hospitalism Trial in Singapore (Horticultural Therapy)
Recruiting
- Frailty
- Hospitalism
- Horticultural Therapy
-
Singapore, SingaporeKhoo Teck Puat Hospital
Sep 28, 2021
Lymphoma, Mantle-cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Hairy Cell Trial run by the NHLBI (ON01910 Na)
Completed
- Lymphoma, Mantle-cell
- +4 more
- ON01910 Na
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2019